Lenvatinib: Revision history

From IDWiki

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

    17 September 2024

    • curprev 15:2715:27, 17 September 2024Aidan talk contribs 393 bytes +393 Created page with "* Multiple receptor tyrosine kinase inhibitor (TKI) that inhibits VEGF receptors * Indicated for thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma * Hypertension is a common side effect * Other adverse effects include heart failure, QT prolongation, renal failure, proteinuria, diarrhea, poor wound healing and fistula formation Category:Oncology Category:Medications" Tag: Visual edit